FIELD: medicine, pharmaceutics.
SUBSTANCE: invention is a pharmaceutical composition for psoriasis and eczema treatment, containing trailing mahonia extract in loposomal delivery system. The extract content in the composition is 5-20% of the composition total weight. The invention also concerns method for production of trailing mahonia extract.
EFFECT: pharmaceutical composition is especially effective for psoriasis and eczema treatment among patients of various degrees of disease.
8 cl
Authors
Dates
2010-05-10—Published
2004-09-22—Filed